These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22777868)

  • 1. Screening rhodium metallopeptide libraries "on bead": asymmetric cyclopropanation and a solution to the enantiomer problem.
    Sambasivan R; Ball ZT
    Angew Chem Int Ed Engl; 2012 Aug; 51(34):8568-72. PubMed ID: 22777868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of asymmetric styrene cyclopropanation with a rhodium(II) metallopeptide catalyst developed with a high-throughput screen.
    Sambasivan R; Ball ZT
    Chirality; 2013 Sep; 25(9):493-7. PubMed ID: 23749505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing enzyme-like catalysts: a rhodium(II) metallopeptide case study.
    Ball ZT
    Acc Chem Res; 2013 Feb; 46(2):560-70. PubMed ID: 23210518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodium N-confused porphyrin-catalyzed alkene cyclopropanation.
    Niino T; Toganoh M; Andrioletti B; Furuta H
    Chem Commun (Camb); 2006 Nov; (41):4335-7. PubMed ID: 17047859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence for the all-up reactive conformation of chiral rhodium(II) carboxylate catalysts: enantioselective synthesis of cis-cyclopropane alpha-amino acids.
    Lindsay VN; Lin W; Charette AB
    J Am Chem Soc; 2009 Nov; 131(45):16383-5. PubMed ID: 19860407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotope effects and the nature of selectivity in rhodium-catalyzed cyclopropanations.
    Nowlan DT; Gregg TM; Davies HM; Singleton DA
    J Am Chem Soc; 2003 Dec; 125(51):15902-11. PubMed ID: 14677982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric Rh(II)-catalyzed cyclopropanation of alkenes with diacceptor diazo compounds: p-methoxyphenyl ketone as a general stereoselectivity controlling group.
    Lindsay VN; Nicolas C; Charette AB
    J Am Chem Soc; 2011 Jun; 133(23):8972-81. PubMed ID: 21548649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-specific inhibition of a designed metallopeptide catalyst.
    Popp BV; Chen Z; Ball ZT
    Chem Commun (Camb); 2012 Aug; 48(60):7492-4. PubMed ID: 22728748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance between allylic C-H activation and cyclopropanation in the reactions of donor/acceptor-substituted rhodium carbenoids with trans-alkenes.
    Davies HM; Coleman MG; Ventura DL
    Org Lett; 2007 Nov; 9(24):4971-4. PubMed ID: 17956111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric catalysis of the [5 + 2] cycloaddition reaction of vinylcyclopropanes and pi-systems.
    Wender PA; Haustedt LO; Lim J; Love JA; Williams TJ; Yoon JY
    J Am Chem Soc; 2006 May; 128(19):6302-3. PubMed ID: 16683779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutually pi-facial selective cyclopropanation of chiral enamides using dirhodium(II) carbenoids.
    Lu T; Song Z; Hsung RP
    Org Lett; 2008 Feb; 10(4):541-4. PubMed ID: 18205371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodium-mediated enantioselective cyclopropanation of allenes.
    Gregg TM; Farrugia MK; Frost JR
    Org Lett; 2009 Oct; 11(19):4434-6. PubMed ID: 19711905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhodium-catalyzed enantioselective cyclopropanation of olefins with N-sulfonyl 1,2,3-triazoles.
    Chuprakov S; Kwok SW; Zhang L; Lercher L; Fokin VV
    J Am Chem Soc; 2009 Dec; 131(50):18034-5. PubMed ID: 19928917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin B12 derivatives as natural asymmetric catalysts: enantioselective cyclopropanation of alkenes.
    Chen Y; Zhang XP
    J Org Chem; 2004 Apr; 69(7):2431-5. PubMed ID: 15049642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial metalloenzymes for enantioselective catalysis based on biotin-avidin.
    Collot J; Gradinaru J; Humbert N; Skander M; Zocchi A; Ward TR
    J Am Chem Soc; 2003 Jul; 125(30):9030-1. PubMed ID: 15369356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of solution-phase phosphoramidite and phosphite ligand libraries and their in situ screening in the rhodium-catalyzed asymmetric addition of arylboronic acids.
    Jagt RB; Toullec PY; Schudde EP; de Vries JG; Feringa BL; Minnaard AJ
    J Comb Chem; 2007; 9(3):407-14. PubMed ID: 17430002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic asymmetric cyclopropanation using bridged dirhodium tetraprolinates on solid support.
    Nagashima T; Davies HM
    Org Lett; 2002 Jun; 4(12):1989-92. PubMed ID: 12049499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering a dirhodium artificial metalloenzyme for selective olefin cyclopropanation.
    Srivastava P; Yang H; Ellis-Guardiola K; Lewis JC
    Nat Commun; 2015 Jul; 6():7789. PubMed ID: 26206238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Rh(I)/Pd-catalyzed 1,4-addition/intramolecular allylation: stereocontrolled construction of gamma-butyrolactones and cyclopropanes.
    Fillion E; Carret S; Mercier LG; Trépanier VE
    Org Lett; 2008 Feb; 10(3):437-40. PubMed ID: 18183992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis of (+)-asteriscanolide: further exploration of the rhodium(I)-catalyzed [(5+2)+1] reaction of ene-vinylcyclopropanes and CO.
    Liang Y; Jiang X; Fu XF; Ye S; Wang T; Yuan J; Wang Y; Yu ZX
    Chem Asian J; 2012 Mar; 7(3):593-604. PubMed ID: 22223465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.